Annotations: 7RMS

Domain Annotation: ECOD Classification ECOD Database Homepage

Chains	Family Name	Domain Identifier	Architecture	Possible Homology	Homology	Topology	Family	Provenance Source (Version)
A	PF03784	e7rmsA1	A: few secondary structure elements	X: omega toxin-like	H: omega toxin-related	T: Cyclotides	F: PF03784	ECOD (1.6)

Protein Family Annotation Pfam Database Homepage

Chains	Accession	Name	Description	Comments	Source
A	PF03784	Cyclotide family (Cyclotide)	Cyclotide family	This family contains a set of cyclic peptides with a variety of activities. The structure consists of a distorted triple-stranded beta-sheet and a cysteine-knot arrangement of the disulfide bonds [2]. Cyclotides can be separated into two subfamilies, ...	This family contains a set of cyclic peptides with a variety of activities. The structure consists of a distorted triple-stranded beta-sheet and a cysteine-knot arrangement of the disulfide bonds [2]. Cyclotides can be separated into two subfamilies, namely bracelet and moebius. The bracelet cyclotide subfamily tends to contain a larger number of positively charged residues and has a bracelet-like circularisation of the backbone [2]. The moebius cyclotide subfamily contains a backbone twist due to a cis-Pro peptide bond and may conceptually be regarded as a molecular Moebius strip [2].	Domain
B	PF03784	Cyclotide family (Cyclotide)	Cyclotide family	This family contains a set of cyclic peptides with a variety of activities. The structure consists of a distorted triple-stranded beta-sheet and a cysteine-knot arrangement of the disulfide bonds [2]. Cyclotides can be separated into two subfamilies, ...	This family contains a set of cyclic peptides with a variety of activities. The structure consists of a distorted triple-stranded beta-sheet and a cysteine-knot arrangement of the disulfide bonds [2]. Cyclotides can be separated into two subfamilies, namely bracelet and moebius. The bracelet cyclotide subfamily tends to contain a larger number of positively charged residues and has a bracelet-like circularisation of the backbone [2]. The moebius cyclotide subfamily contains a backbone twist due to a cis-Pro peptide bond and may conceptually be regarded as a molecular Moebius strip [2].	Domain

Gene Ontology: Gene Product Annotation Gene Ontology Database Homepage

Chains	Polymer	Molecular Function	Biological Process	Cellular Component
A	[I11L]cycloviolacin O2	-	response to stimulus defense response response to stress biological process involved in interspecies interaction between organisms cellular process disruption of cell in another organism disruption of anatomical structure in another organism killing of cells of another organism cell killing	-
B	D-[I11L]cycloviolacin O2	-	response to stimulus defense response response to stress biological process involved in interspecies interaction between organisms cellular process disruption of cell in another organism disruption of anatomical structure in another organism killing of cells of another organism cell killing	-

InterPro: Protein Family Classification InterPro Database Homepage

Chains	Accession	Name	Type
A	IPR012323	Cyclotide, bracelet, conserved site	Conserved Site
A	IPR005535	Cyclotide	Family
A	IPR036146	Cyclotide superfamily	Homologous Superfamily
B	IPR012323	Cyclotide, bracelet, conserved site	Conserved Site
B	IPR005535	Cyclotide	Family
B	IPR036146	Cyclotide superfamily	Homologous Superfamily

Protein Modification Annotation

Modified Residue(s)
Chain	Residue(s)	Description
B	DAL	RESID: AA0111 , AA0191 PSI-MOD : meso-lanthionine MOD:00120 , D-alanine (Ala) MOD:00198 , D-alanine (Ser) MOD:00858 , D-alanine MOD:00862
B	DAR	RESID: AA0111 , AA0191
B	DCY	RESID: AA0111 , AA0191
B	DGL	RESID: AA0111 , AA0191
B	DIL	RESID: AA0111 , AA0191 , AA0192 PSI-MOD : meso-lanthionine MOD:00120 , D-alanine (Ala) MOD:00198 , D-alanine (Ser) MOD:00858 , D-alanine MOD:00862 , D-allo-isoleucine MOD:00199
B	DLE	RESID: AA0111 , AA0191 , AA0192 , AA0197 PSI-MOD : meso-lanthionine MOD:00120 , D-alanine (Ala) MOD:00198 , D-alanine (Ser) MOD:00858 , D-alanine MOD:00862 , D-allo-isoleucine MOD:00199 , D-leucine MOD:00204
B	DLY	RESID: AA0111 , AA0191 , AA0192 , AA0197
B	DPR	RESID: AA0111 , AA0191 , AA0192 , AA0197
B	DSG	RESID: AA0111 , AA0191 , AA0192 , AA0197 , AA0196 , AA0622 PSI-MOD : meso-lanthionine MOD:00120 , D-alanine (Ala) MOD:00198 , D-alanine (Ser) MOD:00858 , D-alanine MOD:00862 , D-allo-isoleucine MOD:00199 , D-leucine MOD:00204 , D-asparagine MOD:00203 , 2-(L-cystein-S-yl)-D-asparagine MOD:01985
B	DSN	RESID: AA0111 , AA0191 , AA0192 , AA0197 , AA0196 , AA0622 , AA0195 , AA0624 PSI-MOD : meso-lanthionine MOD:00120 , D-alanine (Ala) MOD:00198 , D-alanine (Ser) MOD:00858 , D-alanine MOD:00862 , D-allo-isoleucine MOD:00199 , D-leucine MOD:00204 , D-asparagine MOD:00203 , 2-(L-cystein-S-yl)-D-asparagine MOD:01985 , D-serine (Ser) MOD:00202 , D-serine MOD:00891 , D-serine (Cys) MOD:00892 , 2-(L-cystein-S-yl)-D-serine MOD:01987
B	DTR	RESID: AA0111 , AA0191 , AA0192 , AA0197 , AA0196 , AA0622 , AA0195 , AA0624 , AA0198 PSI-MOD : meso-lanthionine MOD:00120 , D-alanine (Ala) MOD:00198 , D-alanine (Ser) MOD:00858 , D-alanine MOD:00862 , D-allo-isoleucine MOD:00199 , D-leucine MOD:00204 , D-asparagine MOD:00203 , 2-(L-cystein-S-yl)-D-asparagine MOD:01985 , D-serine (Ser) MOD:00202 , D-serine MOD:00891 , D-serine (Cys) MOD:00892 , 2-(L-cystein-S-yl)-D-serine MOD:01987 , D-tryptophan MOD:00205
B	DTY	RESID: AA0111 , AA0191 , AA0192 , AA0197 , AA0196 , AA0622 , AA0195 , AA0624 , AA0198
B	DVA	RESID: AA0111 , AA0191 , AA0192 , AA0197 , AA0196 , AA0622 , AA0195 , AA0624 , AA0198 , AA0200 PSI-MOD : meso-lanthionine MOD:00120 , D-alanine (Ala) MOD:00198 , D-alanine (Ser) MOD:00858 , D-alanine MOD:00862 , D-allo-isoleucine MOD:00199 , D-leucine MOD:00204 , D-asparagine MOD:00203 , 2-(L-cystein-S-yl)-D-asparagine MOD:01985 , D-serine (Ser) MOD:00202 , D-serine MOD:00891 , D-serine (Cys) MOD:00892 , 2-(L-cystein-S-yl)-D-serine MOD:01987 , D-tryptophan MOD:00205 , D-valine MOD:00705

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.